Insulin resistance is a central problem in the metabolic syndrome and I and others have demonstrated that it can be induced in vitro by either the damaging effects of saturated fatty acids, oxidants or inflammatory cytokines; however, the situation in vivo is far more complex and needs further investigation, as no efficient therapeutic strategies are currently available for the treatment of type 2